Brophy Wealth Management LLC Invests $737,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Brophy Wealth Management LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 1,500 shares of the medical equipment provider’s stock, valued at approximately $737,000.

Other hedge funds have also added to or reduced their stakes in the company. Hazlett Burt & Watson Inc. increased its position in Intuitive Surgical by 5.8% during the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after acquiring an additional 20 shares during the period. Mitchell Mcleod Pugh & Williams Inc. increased its holdings in shares of Intuitive Surgical by 4.1% during the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock worth $247,000 after purchasing an additional 20 shares during the period. Ullmann Wealth Partners Group LLC raised its position in shares of Intuitive Surgical by 1.6% in the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after buying an additional 21 shares in the last quarter. Meeder Advisory Services Inc. boosted its stake in shares of Intuitive Surgical by 0.3% in the third quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock valued at $3,629,000 after buying an additional 22 shares during the period. Finally, One Wealth Management Investment & Advisory Services LLC grew its position in Intuitive Surgical by 3.4% during the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after buying an additional 23 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

ISRG has been the subject of several analyst reports. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a report on Friday, October 18th. BTIG Research boosted their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research report on Friday, October 18th. Finally, Stifel Nicolaus raised their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $541.33.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $538.86 on Tuesday. The firm has a market cap of $191.93 billion, a PE ratio of 86.63, a price-to-earnings-growth ratio of 5.41 and a beta of 1.38. Intuitive Surgical, Inc. has a 52 week low of $309.80 and a 52 week high of $556.23. The firm’s fifty day moving average is $517.16 and its 200-day moving average is $475.65.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the sale, the senior vice president now owns 273 shares of the company’s stock, valued at approximately $140,595. This represents a 88.63 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 188 shares of Intuitive Surgical stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $101,332.00. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,720,023. This trade represents a 2.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 50,485 shares of company stock valued at $26,128,102. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.